RBR-8dgwp2nRecruitingNot Applicable
Development and validation of a instrument to evaluate Temporomandibular Dysfunctions for use in epidemiological surveys
Departamento de Odontologia, Universidade Federal do Rio Grande do Norte0 sitesStarted: March 7, 2022Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18Y to 0 (—)
Inclusion Criteria
- •Individuals of both sexes, aged over 18 years, with sufficient capacity to respond to the IDE/DTM and DC/TMD instruments, accept to participate after being informed about the purposes of the research and have Brazilian nationality.
Exclusion Criteria
- •Patients with a history of psychiatric illness, or those with clinical symptoms of TMD that make it impossible for dental examination or pain, as well as those who refuse to participate in the research at any of the foreseen stages will be excluded.
Investigators
Similar Trials
Recruiting
Not Applicable
Development and validation of an instrument for the determination of resistance and promotion of coping strategies in people with diabetes mellitusPeople with type 1 or type 2 diabetes mellitusE10E11Type 2 diabetes mellitusType 1 diabetes mellitusDRKS00009413Frankfurt University of Applied Siences60
Not yet recruiting
Phase 1
Assessing the current knowledge,attitude and perception of women towards screening mammography with valid questionnaireCTRI/2018/04/013518A
Not yet recruiting
Phase 3
Developing a questionnaire tool for assessing the adequate signs and symptoms obtained after performing decoction enemaCTRI/2020/04/024893Dr Jithu s
Not yet recruiting
Not Applicable
Evaluating the signs and symptoms of excessive aggravation of doshas (Bahu Dosha Lakshana) before Bio-Purification TherapiesCTRI/2023/02/049973All India Institute Of Ayurveda
Not yet recruiting
Not Applicable
Tool development to assess the knowledge and awareness of adult men towards screening of prostate cancer and testicular cancerCTRI/2021/08/035712A